Literature DB >> 11583113

Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells.

A Wölfler1, H C Caluba, P M Abuja, G Dohr, K Schauenstein, P M Liebmann.   

Abstract

The antioxidant activity of melatonin (MEL) has been considered to constitute part of its physiological as well as pharmacological effects. However, as described herein we found a profound prooxidant activity of micro- to millimolar concentrations of MEL in the human leukemic Jurkat cell line. This prooxidant effect was increased in glutathione-depleted cells and counteracted by antioxidants. As a consequence MEL promoted fas-induced cell death. These data therefore indicate that MEL may be a modulator of the cellular redox status, but does not necessarily act as an intracellular antioxidant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583113     DOI: 10.1016/s0014-5793(01)02680-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

2.  Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.

Authors:  Néstor Prieto-Domínguez; Raquel Ordóñez; Anna Fernández; Carolina Méndez-Blanco; Anna Baulies; Carmen Garcia-Ruiz; José C Fernández-Checa; José L Mauriz; Javier González-Gallego
Journal:  J Pineal Res       Date:  2016-08-19       Impact factor: 13.007

3.  The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells.

Authors:  Hong-Mei Zhang; Yiqiang Zhang; Bin-Xian Zhang
Journal:  J Pineal Res       Date:  2010-10-20       Impact factor: 13.007

4.  Effects of melatonin administration on oxidative stress and daily locomotor activity patterns in goldfish.

Authors:  J F López-Olmeda; M J Bayarri; M A Rol de Lama; J A Madrid; F J Sánchez-Vázquez
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 4.158

5.  Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells.

Authors:  Ignacio Bejarano; Javier Espino; Ana M Marchena; Carmen Barriga; Sergio D Paredes; Ana B Rodríguez; José A Pariente
Journal:  Mol Cell Biochem       Date:  2011-03-23       Impact factor: 3.396

Review 6.  Physiological and metabolic functions of melatonin.

Authors:  J Barrenetxe; P Delagrange; J A Martínez
Journal:  J Physiol Biochem       Date:  2004-03       Impact factor: 4.158

Review 7.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

8.  Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes.

Authors:  Suhua Han; Luis A Espinoza; Hongling Liao; A Hamid Boulares; Mark E Smulson
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

Review 9.  Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.

Authors:  M S Petronek; J M Stolwijk; S D Murray; E J Steinbach; Y Zakharia; G R Buettner; D R Spitz; B G Allen
Journal:  Redox Biol       Date:  2021-01-16       Impact factor: 10.787

10.  Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin.

Authors:  G García-Santos; V Martin; J Rodríguez-Blanco; F Herrera; S Casado-Zapico; A M Sánchez-Sánchez; I Antolín; C Rodríguez
Journal:  Br J Cancer       Date:  2012-03-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.